Multivalent Bi‐Specific Nanoerythrosomes: A Two‐Birds‐One‐Stone Approach to Combine Homologous and Active Targeting for Effective Thrombolysis
Small · 2026-08 · 22 (47)
DOI: 10.1002/smll.74578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 13.07.2026. Verfasst von Yu Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, UK. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Nanoparticles, Erythrocytes. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Imperial Biomedical Research Centre, Imperial College UKRI Impact Acceleration Account, Rosetrees Trust.
Abstract (Originalsprache)
Combining homologous targeting and active targeting to a thrombus is highly desirable in targeted thrombolytic therapy. Here, we report a multivalent bi‐specific nanoerythrosome for thrombus‐targeted delivery of tissue plasminogen activator (tPA) (denoted as mBiNE@tPA) to achieve effective thrombolysis. This bio‐inspired delivery system was fabricated to exploit two main thrombus components by utilizing the natural erythrocyte membrane for homologous targeting to a thrombus and fibrinogen‐derived cyclic arginine‐glycine‐aspartic acid (cRGD) motifs for active targeting to activated platelets. mBiNE@tPA maintained tPA's activity during extended circulation. Its preferential thrombus accumulation, enhanced thrombus penetration, and triggered tPA release locally through the combined homologous and active thrombus targeting were demonstrated. Efficient and selective fibrinolysis and thrombolysis both in vitro and in vivo were achieved, leading to effective vascular recanalization with minimal hemorrhagic risks in mice. Through the combined experimental and computational work, mBiNE@tPA exhibited superior thrombolytic capabilities over formulations with single or no targeting specificity and free tPA. This nanoerythrosome represents a promising platform for targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, UK.
- Department of Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Sixth People's Hospital, Shanghai, P. R. China.
- School of Chemical Engineering, Chonnam National University, Gwangju, Republic of Korea.
- Biotherapeutics Section, National Institute for Biological Standards and Control, South Mimms, Hertfordshire, UK.
- National Heart and Lung Institute, Imperial College London, London, UK.
ORCID-Profile: Boram Gu, Rongjun Chen
Förderung
- NIHR Imperial Biomedical Research Centre
- Imperial College UKRI Impact Acceleration Account
- Rosetrees Trust
- Imperial College DT-Prime
- Imperial College Chemical Engineering Pre-seed Fund
- National Natural Science Foundation of China
- Fundamental Research Funds for the Shanghai Sixth People's Hospital
- Interdisciplinary Program of Shanghai Jiao Tong University
Zitieren
APA
Huang, Y., Yang, Y., Henry, N., Gu, B., Wang, J., Guo, Y., Longstaff, C., Thom, S. A., Li, Y., Xu, X. Y., & Chen, R. (2026). Multivalent Bi‐Specific Nanoerythrosomes: A Two‐Birds‐One‐Stone Approach to Combine Homologous and Active Targeting for Effective Thrombolysis. Small, 22(47). https://doi.org/10.1002/smll.74578
Vancouver
Huang Y, Yang Y, Henry N, Gu B, Wang J, Guo Y, et al. Multivalent Bi‐Specific Nanoerythrosomes: A Two‐Birds‐One‐Stone Approach to Combine Homologous and Active Targeting for Effective Thrombolysis. Small. 2026;22(47). doi:10.1002/smll.74578
BibTeX
@article{Huang2026,
author = {Huang, Yu and Yang, Yilin and Henry, Nicole and Gu, Boram and Wang, Jiahua and Guo, Yuanyuan and Longstaff, Colin and Thom, Simon A and Li, Yuehua and Xu, Xiao Yun and Chen, Rongjun},
title = {Multivalent Bi‐Specific Nanoerythrosomes: A Two‐Birds‐One‐Stone Approach to Combine Homologous and Active Targeting for Effective Thrombolysis},
journal = {Small},
year = {2026},
volume = {22},
number = {47},
doi = {10.1002/smll.74578}
}
EUVIMED